Lv1
90 积分 2026-03-03 加入
Risk Assessment, Detection and Control of Mutagenic Impurities in Pharmaceuticals: Emphasis on Nitrosamines
4天前
已完结
Analytical Method Development Strategy for Controlling Two New Nitrosamine Drug Substance Related Impurities (NDSRIs) in a Pharmaceutical Drug Product for Treatment of a Rare Disease
1个月前
已完结
Advantages and limitations of the inclusion of ascorbic acid on nitrosamine mitigation in pharmaceutical drug products
1个月前
已关闭
Navigating the complexities in characterization of NDSRIs using advanced analytical techniques
1个月前
已完结
Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanide
1个月前
已完结
Development of a fast RP-HPLC method for the separation of nifurtimox and its forced degradation products through a design of experiment approach
2个月前
已关闭
皖公网安备34019202002308
